{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:02:48Z","timestamp":1789560168235,"version":"build-2803163510"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12759-x","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:08:29Z","timestamp":1789556909000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Amino acid transporters in hepatocellular carcinoma: Gatekeepers of metabolic reprogramming"],"prefix":"10.1007","volume":"53","author":[{"given":"Joys Rachel","family":"Immanuel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zioni Sangeetha","family":"Shankaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maheswaran","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon F.D.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben S","family":"Ashok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Chand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1370-5205","authenticated-orcid":false,"given":"Charles Emmanuel Jebaraj","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"12759_CR1","doi-asserted-by":"publisher","first-page":"e2200118","DOI":"10.1200\/GO.22.00118","volume":"8","author":"VV Shetty","year":"2022","unstructured":"Shetty VV, Kellarai A (2022) Comprehensive Review of Hepatocellular Carcinoma in India: Current Challenges and Future Directions. JCO Glob Oncol 8:e2200118","journal-title":"JCO Glob Oncol"},{"key":"12759_CR2","unstructured":"Cancer Today (2025) In World Health Organization. https:\/\/gco.iarc.who.int\/today\/. Accessed December 02"},{"key":"12759_CR3","doi-asserted-by":"publisher","first-page":"102508","DOI":"10.1016\/j.clinre.2024.102508","volume":"49","author":"S Paranthaman","year":"2025","unstructured":"Paranthaman S, Hani U, Osmani RAM, Bhosale RR, Haider N (2025) Current advances in nanoparticle-based approaches for the hepatocellular carcinoma treatment. Clincal Res Hepatol Gastroenterol 49:102508","journal-title":"Clincal Res Hepatol Gastroenterol"},{"key":"12759_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.25259\/ijmr_285_24","volume":"160","author":"M Shrivastava","year":"2024","unstructured":"Shrivastava M, Agrawal A, Das S, Mishra S (2024) Burden of hepatitis B in asymptomatic blood donor population of India: A systematic review & meta-analysis. Indian J Med Res 160:155\u2013164","journal-title":"Indian J Med Res"},{"key":"12759_CR5","doi-asserted-by":"publisher","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology (Baltimore MD) 64. https:\/\/doi.org\/10.1002\/hep.28431","DOI":"10.1002\/hep.28431"},{"key":"12759_CR6","doi-asserted-by":"publisher","unstructured":"Kulik L, El-Serag HB (2019) Epidemiology and Management of Hepatocellular Carcinoma. Gastroenterology 156. https:\/\/doi.org\/10.1053\/j.gastro.2018.08.065","DOI":"10.1053\/j.gastro.2018.08.065"},{"key":"12759_CR7","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/j.jceh.2014.05.013","volume":"4","author":"SK Acharya","year":"2014","unstructured":"Acharya SK (2014) Epidemiology of Hepatocellular Carcinoma in India. J Clin Experimental Hepatol 4:S27","journal-title":"J Clin Experimental Hepatol"},{"key":"12759_CR8","doi-asserted-by":"publisher","unstructured":"McGlynn KA, Petrick JL, El-Serag HB (2021) Epidemiology of Hepatocellular Carcinoma. Hepatology (Baltimore MD) 73(Suppl 1). https:\/\/doi.org\/10.1002\/hep.31288","DOI":"10.1002\/hep.31288"},{"key":"12759_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0014-7","author":"HK Seitz","year":"2018","unstructured":"Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C et al (2018) Alcoholic liver disease. Nat reviews Disease primers. https:\/\/doi.org\/10.1038\/s41572-018-0014-7","journal-title":"Nat reviews Disease primers"},{"key":"12759_CR10","doi-asserted-by":"publisher","unstructured":"Nagral A, Sarma MS, Matthai J, Kukkle PL, Devarbhavi H, Sinha S et al (2019) Wilson\u2019s Disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India. J Clin experimental Hepatol 9. https:\/\/doi.org\/10.1016\/j.jceh.2018.08.009","DOI":"10.1016\/j.jceh.2018.08.009"},{"key":"12759_CR11","doi-asserted-by":"publisher","unstructured":"Colli A, Fraquelli M, Casazza G, Massironi S, Colucci A, Conte D et al (2006) Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol 101. https:\/\/doi.org\/10.1111\/j.1572-0241.2006.00467.x","DOI":"10.1111\/j.1572-0241.2006.00467.x"},{"key":"12759_CR12","doi-asserted-by":"publisher","unstructured":"Arvind A, Joshi S, Zaki T, Burkholder D, Parikh ND, Singal AG (2023) Risk of Hepatocellular Carcinoma in Patients With Indeterminate (LI-RADS 3) Liver Observations. Clinical gastroenterology and hepatology: the official clinical practice. J Am Gastroenterological Association 21. https:\/\/doi.org\/10.1016\/j.cgh.2021.11.042","DOI":"10.1016\/j.cgh.2021.11.042"},{"key":"12759_CR13","doi-asserted-by":"publisher","unstructured":"Chakraborty E, Sarkar D (2022) Emerging Therapies for Hepatocellular Carcinoma (HCC). Cancers 14. https:\/\/doi.org\/10.3390\/cancers14112798","DOI":"10.3390\/cancers14112798"},{"key":"12759_CR14","doi-asserted-by":"publisher","unstructured":"Sangro B, Sarobe P, Herv\u00e1s-Stubbs S, Melero I (2021) Advances in immunotherapy for hepatocellular carcinoma. Nat reviews Gastroenterol Hepatol 18. https:\/\/doi.org\/10.1038\/s41575-021-00438-0","DOI":"10.1038\/s41575-021-00438-0"},{"key":"12759_CR15","doi-asserted-by":"publisher","unstructured":"Chen Q, Zheng W, Guan J, Liu H, Dan Y, Zhu L et al (2023) SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma. Cell Death Differ 30. https:\/\/doi.org\/10.1038\/s41418-022-01051-7","DOI":"10.1038\/s41418-022-01051-7"},{"key":"12759_CR16","doi-asserted-by":"publisher","unstructured":"He F, Zhang P, Liu J, Wang R, Kaufman RJ, Yaden BC et al (2023) ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis. J Hepatol 79. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.016","DOI":"10.1016\/j.jhep.2023.03.016"},{"key":"12759_CR17","doi-asserted-by":"publisher","unstructured":"Bothwell PJ, Kron CD, Wittke EF, Czerniak BN, Bode BP (2018) Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth. Int J Mol Sci 19. https:\/\/doi.org\/10.3390\/ijms19072093","DOI":"10.3390\/ijms19072093"},{"key":"12759_CR18","doi-asserted-by":"publisher","unstructured":"Namikawa M, Kakizaki S, Kaira K, Tojima H, Yamazaki Y, Horiguchi N et al (2015) Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma. Hepatol research: official J Japan Soc Hepatol 45. https:\/\/doi.org\/10.1111\/hepr.12431","DOI":"10.1111\/hepr.12431"},{"key":"12759_CR19","doi-asserted-by":"crossref","unstructured":"Kondoh N, Imazeki N, Arai M, Hada A, Hatsuse K, Matsuo H et al (2007) Activation of a system A amino acid transporter, ATA1\/SLC38A1, in human hepatocellular carcinoma and preneoplastic liver tissues. Int J Oncol. 2007;31(1):81-87. https:\/\/pubmed.ncbi.nlm.nih.gov\/17549407\/","DOI":"10.3892\/ijo.31.1.81"},{"key":"12759_CR20","doi-asserted-by":"publisher","unstructured":"Du D, Liu C, Qin M, Zhang X, Xi T, Yuan S et al (2022) Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharm Sinica B 12. https:\/\/doi.org\/10.1016\/j.apsb.2021.09.019","DOI":"10.1016\/j.apsb.2021.09.019"},{"key":"12759_CR21","doi-asserted-by":"publisher","first-page":"963066","DOI":"10.3389\/fphar.2022.963066","volume":"13","author":"G Gauthier-Coles","year":"2022","unstructured":"Gauthier-Coles G, Br\u00f6er A, McLeod MD, George AJ, Hannan RD, Br\u00f6er S (2022) Identification and characterization of a novel SNAT2 (SLC38A2) inhibitor reveals synergy with glucose transport inhibition in cancer cells. Front Pharmacol 13:963066","journal-title":"Front Pharmacol"},{"key":"12759_CR22","doi-asserted-by":"publisher","unstructured":"Li J, Qiang J, Chen SF, Wang X, Fu J, Chen Y (2013) The impact of L-type amino acid transporter 1 (LAT1) in human hepatocellular carcinoma. Tumour biology: J Int Soc Oncodevelopmental Biology Med 34. https:\/\/doi.org\/10.1007\/s13277-013-0861-5","DOI":"10.1007\/s13277-013-0861-5"},{"key":"12759_CR23","doi-asserted-by":"publisher","unstructured":"Kim SY, Ong Q, Liao Y, Ding Z, Tan AQL, Lim LTR et al (2023) Genetic Ablation of LAT1 Inhibits Growth of Liver Cancer Cells and Downregulates mTORC1 Signaling. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms24119171","DOI":"10.3390\/ijms24119171"},{"key":"12759_CR24","doi-asserted-by":"publisher","unstructured":"Ge NJ, Shi ZY, Yu XH, Huang XJ, Wu YS, Chen YY et al (2015) Genetic Variants in ASCT2 Gene are Associated with the Prognosis of Transarterial Chemoembolisation-Treated Early- Stage Hepatocelluar Carcinoma. Asian Pac J cancer prevention: APJCP 16. https:\/\/doi.org\/10.7314\/apjcp.2015.16.9.4103","DOI":"10.7314\/apjcp.2015.16.9.4103"},{"key":"12759_CR25","doi-asserted-by":"publisher","unstructured":"Jiang J, Dong W, Zhang W, Wang Q, Wang R, Wang J et al (2023) LncRNA SLC1A5-AS\/MZF1\/ASCT2 Axis Contributes to Malignant Progression of Hepatocellular Carcinoma. Discov Med 35. https:\/\/doi.org\/10.24976\/Discov.Med.202335179.96","DOI":"10.24976\/Discov.Med.202335179.96"},{"key":"12759_CR26","doi-asserted-by":"publisher","unstructured":"Iseda N, Itoh S, Toshida K, Tomiyama T, Morinaga A, Shimokawa M et al (2022) Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor-4 inhibition in hepatocellular carcinoma. Cancer Sci 113. https:\/\/doi.org\/10.1111\/cas.15378","DOI":"10.1111\/cas.15378"},{"key":"12759_CR27","doi-asserted-by":"publisher","unstructured":"Tang B, Zhu J, Wang Y, Chen W, Fang S, Mao W et al (2023) Targeted xCT-mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti-PD-1\/L1 Response. Adv Sci (Weinheim Baden-Wurttemberg Germany) 10. https:\/\/doi.org\/10.1002\/advs.202203973","DOI":"10.1002\/advs.202203973"},{"key":"12759_CR28","doi-asserted-by":"publisher","unstructured":"Guo W, Zhao Y, Zhang Z, Tan N, Zhao F, Ge C et al (2011) Disruption of xCT inhibits cell growth via the ROS\/autophagy pathway in hepatocellular carcinoma. Cancer Lett 312. https:\/\/doi.org\/10.1016\/j.canlet.2011.07.024","DOI":"10.1016\/j.canlet.2011.07.024"},{"key":"12759_CR29","doi-asserted-by":"publisher","unstructured":"Fan SJ, Goberdhan DCI (2018) PATs and SNATs: Amino Acid Sensors in Disguise. Front Pharmacol 9. https:\/\/doi.org\/10.3389\/fphar.2018.00640","DOI":"10.3389\/fphar.2018.00640"},{"key":"12759_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-019-0582-4","volume":"2","author":"D Yamada","year":"2019","unstructured":"Yamada D, Kawabe K, Tosa I, Tsukamoto S, Nakazato R, Kou M et al (2019) Inhibition of the glutamine transporter SNAT1 confers neuroprotection in mice by modulating the mTOR-autophagy system. Commun Biology 2:1\u201311","journal-title":"Commun Biology"},{"key":"12759_CR31","first-page":"532023","volume":"8","author":"T Li","year":"2020","unstructured":"Li T, Zhang G, Wang L, Li S, Xu X, Gao Y (2020) Defects in mTORC1 Network and mTORC1-STAT3 Pathway Crosstalk Contributes to Non-inflammatory Hepatocellular Carcinoma. Front Cell Dev Biol 8:532023","journal-title":"Front Cell Dev Biol"},{"key":"12759_CR32","doi-asserted-by":"publisher","unstructured":"Li J, Wang WQ, Zhu RH, Lv X, Wang JL, Liang BY et al (2023) Postoperative adjuvant tyrosine kinase inhibitors combined with anti-PD-1 antibodies improves surgical outcomes for hepatocellular carcinoma with high-risk recurrent factors. Front Immunol 14. https:\/\/doi.org\/10.3389\/fimmu.2023.1202039","DOI":"10.3389\/fimmu.2023.1202039"},{"key":"12759_CR33","doi-asserted-by":"crossref","unstructured":"Halestrap AP, Price NT (1999) The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J. 1999;343 Pt 2(Pt 2):281-299. https:\/\/pubmed.ncbi.nlm.nih.gov\/10510291\/","DOI":"10.1042\/bj3430281"},{"key":"12759_CR34","doi-asserted-by":"publisher","unstructured":"Goberdhan DC, Meredith D, Boyd CA, Wilson C (2005) PAT-related amino acid transporters regulate growth via a novel mechanism that does not require bulk transport of amino acids. Development 132. https:\/\/doi.org\/10.1242\/dev.01821","DOI":"10.1242\/dev.01821"},{"key":"12759_CR35","doi-asserted-by":"publisher","unstructured":"Thwaites DT, Anderson CM (2011) The SLC36 family of proton-coupled amino acid transporters and their potential role in drug transport. Br J Pharmacol 164. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01438.x","DOI":"10.1111\/j.1476-5381.2011.01438.x"},{"key":"12759_CR36","doi-asserted-by":"publisher","unstructured":"Pillai SM, Meredith D (2011) SLC36A4 (hPAT4) is a high affinity amino acid transporter when expressed in Xenopus laevis oocytes. J Biol Chem 286. https:\/\/doi.org\/10.1074\/jbc.M110.172403","DOI":"10.1074\/jbc.M110.172403"},{"key":"12759_CR37","doi-asserted-by":"publisher","first-page":"e36616","DOI":"10.1371\/journal.pone.0036616","volume":"7","author":"MH \u00d6gmundsd\u00f3ttir","year":"2012","unstructured":"\u00d6gmundsd\u00f3ttir MH, Heublein S, Kazi S, Reynolds B, Visvalingam SM, Shaw MK et al (2012) Proton-Assisted Amino Acid Transporter PAT1 Complexes with Rag GTPases and Activates TORC1 on Late Endosomal and Lysosomal Membranes. PLoS ONE 7:e36616","journal-title":"PLoS ONE"},{"key":"12759_CR38","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41568-023-00612-3","volume":"23","author":"A Sajid","year":"2023","unstructured":"Sajid A, Rahman H, Ambudkar SV (2023) Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters. Nat Rev Cancer 23:762\u2013779","journal-title":"Nat Rev Cancer"},{"key":"12759_CR39","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jes.2021.12.001","volume":"124","author":"J Mo","year":"2023","unstructured":"Mo J, Ma Z, Yan S, Cheung NK, Yang F, Yao X et al (2023) Metabolomic profiles in a green alga (Raphidocelis subcapitata) following erythromycin treatment: ABC transporters and energy metabolism. J Environ Sci (China) 124:591\u2013601","journal-title":"J Environ Sci (China)"},{"key":"12759_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12903-023-02722-8","volume":"23","author":"K Li","year":"2023","unstructured":"Li K, Wang J, Du N, Sun Y, Sun Q, Yin W et al (2023) Salivary microbiome and metabolome analysis of severe early childhood caries. BMC Oral Health 23:30","journal-title":"BMC Oral Health"},{"key":"12759_CR41","doi-asserted-by":"publisher","first-page":"e2200432","DOI":"10.1002\/pmic.202200432","volume":"23","author":"H Hong","year":"2023","unstructured":"Hong H, Chen X, Wang H, Gu X, Yuan Y, Zhang Z (2023) Global profiling of protein lysine lactylation and potential target modified protein analysis in hepatocellular carcinoma. Proteomics 23:e2200432","journal-title":"Proteomics"},{"key":"12759_CR42","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1111\/mec.16497","volume":"31","author":"J Hearn","year":"2022","unstructured":"Hearn J, Djoko Tagne CS, Ibrahim SS, Tene-Fossog B, Mugenzi LMJ, Irving H et al (2022) Multi-omics analysis identifies a CYP9K1 haplotype conferring pyrethroid resistance in the malaria vector Anopheles funestus in East Africa. Mol Ecol 31:3642\u20133657","journal-title":"Mol Ecol"},{"key":"12759_CR43","doi-asserted-by":"publisher","first-page":"106835","DOI":"10.1016\/j.aquatox.2024.106835","volume":"267","author":"X Bi","year":"2024","unstructured":"Bi X, Qiu M, Li D, Zhang Y, Zhan W, Wang Z et al (2024) Transcriptomic and metabolomic analysis of the mechanisms underlying stress responses of the freshwater snail, Pomacea canaliculata, exposed to different levels of arsenic. Aquat Toxicol 267:106835","journal-title":"Aquat Toxicol"},{"key":"12759_CR44","doi-asserted-by":"publisher","first-page":"5825","DOI":"10.1093\/nar\/gkae309","volume":"52","author":"Y Chadani","year":"2024","unstructured":"Chadani Y, Yamanouchi S, Uemura E, Yamasaki K, Niwa T, Ikeda T et al (2024) The ABCF proteins in Escherichia coli individually cope with hard-to-translate nascent peptide sequences. Nucleic Acids Res 52:5825\u20135840","journal-title":"Nucleic Acids Res"},{"key":"12759_CR45","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41416-020-0912-9","volume":"123","author":"G Li Petri","year":"2020","unstructured":"Li Petri G, El Hassouni B, Sciarrillo R, Funel N, Mantini G, van der Zeeuw EA et al (2020) Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds. Br J Cancer 123:644\u2013656","journal-title":"Br J Cancer"},{"key":"12759_CR46","doi-asserted-by":"publisher","first-page":"602668","DOI":"10.3389\/fcell.2020.602668","volume":"8","author":"G Venkateswaran","year":"2020","unstructured":"Venkateswaran G, Dedhar S (2020) Interplay of Carbonic Anhydrase IX With Amino Acid and Acid\/Base Transporters in the Hypoxic Tumor Microenvironment. Front Cell Dev Biol 8:602668","journal-title":"Front Cell Dev Biol"},{"key":"12759_CR47","doi-asserted-by":"publisher","first-page":"e0115153","DOI":"10.1371\/journal.pone.0115153","volume":"10","author":"M Yu","year":"2015","unstructured":"Yu M, Zhou Q, Zhou Y, Fu Z, Tan L, Ye X et al (2015) Metabolic Phenotypes in Pancreatic Cancer. PLoS ONE 10:e0115153","journal-title":"PLoS ONE"},{"key":"12759_CR48","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/s41388-019-1098-6","volume":"39","author":"S Ames","year":"2019","unstructured":"Ames S, Andring JT, McKenna R, Becker HM (2019) CAIX forms a transport metabolon with monocarboxylate transporters in human breast cancer cells. Oncogene 39:1710\u20131723","journal-title":"Oncogene"},{"key":"12759_CR49","doi-asserted-by":"publisher","first-page":"116021","DOI":"10.1016\/j.biopha.2023.116021","volume":"170","author":"Q Wang","year":"2024","unstructured":"Wang Q, Liu J, Chen Z, Zheng J, Wang Y, Dong J (2024) Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review. Biomed Pharmacother 170:116021","journal-title":"Biomed Pharmacother"},{"key":"12759_CR50","doi-asserted-by":"publisher","unstructured":"Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma (2017) Cell 169. https:\/\/doi.org\/10.1016\/j.cell.2017.05.046","DOI":"10.1016\/j.cell.2017.05.046"},{"key":"12759_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-022-00919-y","volume":"12","author":"L Zhao","year":"2022","unstructured":"Zhao L, Su H, Liu X, Wang H, Feng Y, Wang Y et al (2022) mTORC1-c-Myc pathway rewires methionine metabolism for HCC progression through suppressing SIRT4 mediated ADP ribosylation of MAT2A. Cell Bioscience 12:1\u201319","journal-title":"Cell Bioscience"},{"key":"12759_CR52","doi-asserted-by":"publisher","unstructured":"Tian LY, Smit DJ, J\u00fccker M (2023) The Role of PI3K\/AKT\/mTOR Signaling in Hepatocellular Carcinoma Metabolism. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms24032652","DOI":"10.3390\/ijms24032652"},{"key":"12759_CR53","doi-asserted-by":"publisher","unstructured":"Llovet JM, Bruix J (2008) Molecular targeted therapies in hepatocellular carcinoma. Hepatology (Baltimore MD) 48. https:\/\/doi.org\/10.1002\/hep.22506","DOI":"10.1002\/hep.22506"},{"key":"12759_CR54","doi-asserted-by":"publisher","unstructured":"Couri T, Pillai A (2019) Goals and targets for personalized therapy for HCC. Hep Intl 13. https:\/\/doi.org\/10.1007\/s12072-018-9919-1","DOI":"10.1007\/s12072-018-9919-1"},{"key":"12759_CR55","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41418-024-01270-0","volume":"31","author":"Y Du","year":"2024","unstructured":"Du Y, Zhou Y, Yan X, Pan F, He L, Guo Z et al (2024) APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell Death Differ 31:431\u2013446","journal-title":"Cell Death Differ"},{"key":"12759_CR56","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/JLB.3MA1220-815RRR","volume":"110","author":"R Kong","year":"2021","unstructured":"Kong R, Wang N, Han W, Bao W, Lu J (2021) IFN\u03b3-mediated repression of system xc drives vulnerability to induced ferroptosis in hepatocellular carcinoma cells. J Leukoc Biol 110:301\u2013314","journal-title":"J Leukoc Biol"},{"key":"12759_CR57","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13046-019-1177-0","volume":"38","author":"W Li","year":"2019","unstructured":"Li W, Dong X, He C, Tan G, Li Z, Zhai B et al (2019) LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells. J Experimental Clin Cancer Res 38:183","journal-title":"J Experimental Clin Cancer Res"},{"key":"12759_CR58","doi-asserted-by":"publisher","first-page":"e18335","DOI":"10.1111\/jcmm.18335","volume":"28","author":"J Ji","year":"2024","unstructured":"Ji J, Cheng Z, Zhang J, Wu J, Xu X, Guo C et al (2024) Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4-xCT pathway. J Cell Mol Med 28:e18335","journal-title":"J Cell Mol Med"},{"key":"12759_CR59","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/mc.23527","volume":"62","author":"J Chen","year":"2023","unstructured":"Chen J, Zhang J, Tian W, Ge C, Su Y, Li J et al (2023) AKR1C3 suppresses ferroptosis in hepatocellular carcinoma through regulation of YAP\/SLC7A11 signaling pathway. Mol Carcinog 62:833\u2013844","journal-title":"Mol Carcinog"},{"key":"12759_CR60","doi-asserted-by":"publisher","unstructured":"Rebouissou S, Nault JC (2020) Advances in molecular classification and precision oncology in hepatocellular carcinoma. J Hepatol 72. https:\/\/doi.org\/10.1016\/j.jhep.2019.08.017","DOI":"10.1016\/j.jhep.2019.08.017"},{"key":"12759_CR61","doi-asserted-by":"publisher","unstructured":"Whittaker S, Marais R, Zhu AX (2010) The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 29. https:\/\/doi.org\/10.1038\/onc.2010.236","DOI":"10.1038\/onc.2010.236"},{"key":"12759_CR62","doi-asserted-by":"publisher","first-page":"1242059","DOI":"10.3389\/fmolb.2023.1242059","volume":"10","author":"Y Ye","year":"2023","unstructured":"Ye Y, Yu B, Wang H, Yi F (2023) Glutamine metabolic reprogramming in hepatocellular carcinoma. Front Mol Biosci 10:1242059","journal-title":"Front Mol Biosci"},{"key":"12759_CR63","doi-asserted-by":"publisher","unstructured":"Wang Q, Guo Y, Wang W, Liu B, Yang G, Xu Z et al (2021) RNA binding protein DAZAP1 promotes HCC progression and regulates ferroptosis by interacting with SLC7A11 mRNA. Exp Cell Res 399. https:\/\/doi.org\/10.1016\/j.yexcr.2020.112453","DOI":"10.1016\/j.yexcr.2020.112453"},{"key":"12759_CR64","doi-asserted-by":"crossref","unstructured":"Amino (2022) acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics. Pharmacology & Therapeutics 230:107964","DOI":"10.1016\/j.pharmthera.2021.107964"},{"key":"12759_CR65","doi-asserted-by":"publisher","unstructured":"Rosilio C, Nebout M, Imbert V, Griessinger E, Neffati Z, Benadiba J et al (2015) L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma\/T-cell acute lymphoblastic leukemia. Leukemia 29. https:\/\/doi.org\/10.1038\/leu.2014.338","DOI":"10.1038\/leu.2014.338"},{"key":"12759_CR66","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nm.4464","volume":"24","author":"ML Schulte","year":"2018","unstructured":"Schulte ML, Fu A, Zhao P, Li J, Geng L, Smith ST et al (2018) Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models. Nat Med 24:194\u2013202","journal-title":"Nat Med"},{"key":"12759_CR67","doi-asserted-by":"publisher","unstructured":"Koppula P, Zhuang L, Gan B (2021) Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 12. https:\/\/doi.org\/10.1007\/s13238-020-00789-5","DOI":"10.1007\/s13238-020-00789-5"},{"key":"12759_CR68","doi-asserted-by":"publisher","unstructured":"Timmerman LA, Holton T, Yuneva M, Louie RJ, Padr\u00f3 M, Daemen A et al (2013) Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. Cancer Cell 24. https:\/\/doi.org\/10.1016\/j.ccr.2013.08.020","DOI":"10.1016\/j.ccr.2013.08.020"},{"key":"12759_CR69","doi-asserted-by":"publisher","unstructured":"Global change in (2022) hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study. lancet Gastroenterol Hepatol 7. https:\/\/doi.org\/10.1016\/S2468-1253(21)00472-6","DOI":"10.1016\/S2468-1253(21)00472-6"},{"key":"12759_CR70","doi-asserted-by":"publisher","unstructured":"Kota J, Chivukula RR, O\u2019Donnell KA, Wentzel EA, Montgomery CL, Hwang HW et al (2009) Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137. https:\/\/doi.org\/10.1016\/j.cell.2009.04.021","DOI":"10.1016\/j.cell.2009.04.021"},{"key":"12759_CR71","doi-asserted-by":"publisher","unstructured":"Hong DS, Kang YK, Borad M, Sachdev J, Ejadi S, Lim HY et al (2020) Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br J Cancer 122. https:\/\/doi.org\/10.1038\/s41416-020-0802-1","DOI":"10.1038\/s41416-020-0802-1"},{"key":"12759_CR72","doi-asserted-by":"publisher","unstructured":"Shi X, Sun M, Liu H, Yao Y, Song Y (2013) Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett 339. https:\/\/doi.org\/10.1016\/j.canlet.2013.06.013","DOI":"10.1016\/j.canlet.2013.06.013"},{"key":"12759_CR73","doi-asserted-by":"publisher","unstructured":"Tang X, Ren H, Guo M, Qian J, Yang Y, Gu C (2021) Review on circular RNAs and new insights into their roles in cancer. Comput Struct Biotechnol J 19. https:\/\/doi.org\/10.1016\/j.csbj.2021.01.018","DOI":"10.1016\/j.csbj.2021.01.018"},{"key":"12759_CR74","doi-asserted-by":"publisher","unstructured":"Duan H, Liu Y, Gao Z, Huang W (2021) Recent advances in drug delivery systems for targeting cancer stem cells. Acta Pharm Sinica B 11. https:\/\/doi.org\/10.1016\/j.apsb.2020.09.016","DOI":"10.1016\/j.apsb.2020.09.016"},{"key":"12759_CR75","doi-asserted-by":"publisher","unstructured":"Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ et al (2016) Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hep Intl 10. https:\/\/doi.org\/10.1007\/s12072-015-9675-4","DOI":"10.1007\/s12072-015-9675-4"},{"key":"12759_CR76","doi-asserted-by":"publisher","unstructured":"Yang C, Zhang H, Zhang L, Zhu AX, Bernards R, Qin W et al (2023) Evolving therapeutic landscape of advanced hepatocellular carcinoma. Nat reviews Gastroenterol Hepatol 20. https:\/\/doi.org\/10.1038\/s41575-022-00704-9","DOI":"10.1038\/s41575-022-00704-9"},{"key":"12759_CR77","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1186\/s12951-024-02808-7","volume":"22","author":"L Wang","year":"2024","unstructured":"Wang L, Tong L, Xiong Z, Chen Y, Zhang P, Gao Y et al (2024) Ferroptosis-inducing nanomedicine and targeted short peptide for synergistic treatment of hepatocellular carcinoma. J Nanobiotechnol 22:533","journal-title":"J Nanobiotechnol"},{"key":"12759_CR78","doi-asserted-by":"publisher","unstructured":"Ganesan P, Kulik LM (2023) Hepatocellular Carcinoma: New Developments. Clinics in liver disease. 27. https:\/\/doi.org\/10.1016\/j.cld.2022.08.004","DOI":"10.1016\/j.cld.2022.08.004"},{"key":"12759_CR79","doi-asserted-by":"publisher","unstructured":"Wang Y, Deng B (2023) Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev 42. https:\/\/doi.org\/10.1007\/s10555-023-10084-4","DOI":"10.1007\/s10555-023-10084-4"},{"key":"12759_CR80","doi-asserted-by":"publisher","unstructured":"Singal AG, Llovet JM, Yarchoan M, Mehta N, Heimbach JK, Dawson LA et al (2023) AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology (Baltimore MD) 78. https:\/\/doi.org\/10.1097\/HEP.0000000000000466","DOI":"10.1097\/HEP.0000000000000466"},{"key":"12759_CR81","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1002\/hep.32062","volume":"74","author":"Q He","year":"2021","unstructured":"He Q, Liu M, Huang W, Chen X, Zhang B, Zhang T et al (2021) IL-1\u03b2-Induced Elevation of Solute Carrier Family 7 Member 11 Promotes Hepatocellular Carcinoma Metastasis Through Up-regulating Programmed Death Ligand 1 and Colony-Stimulating Factor 1. Hepatology 74:3174\u20133193","journal-title":"Hepatology"},{"key":"12759_CR82","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jhep.2023.10.024","volume":"80","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Wei T, Jin W, Yan L, Shi L, Zhu S et al (2024) Deficiency in SLC25A15, a hypoxia-responsive gene, promotes hepatocellular carcinoma by reprogramming glutamine metabolism. J Hepatol 80:293\u2013308","journal-title":"J Hepatol"},{"key":"12759_CR83","doi-asserted-by":"publisher","unstructured":"Filliol A, Saito Y, Nair A, Dapito DH, Yu LX, Ravichandra A et al (2022) Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. Nature 610. https:\/\/doi.org\/10.1038\/s41586-022-05289-6","DOI":"10.1038\/s41586-022-05289-6"},{"key":"12759_CR84","doi-asserted-by":"publisher","unstructured":"Estes C, Anstee QM, Arias-Loste MT, Bantel H, Bellentani S, Caballeria J et al (2018) Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030. J Hepatol 69. https:\/\/doi.org\/10.1016\/j.jhep.2018.05.036","DOI":"10.1016\/j.jhep.2018.05.036"},{"key":"12759_CR85","doi-asserted-by":"publisher","unstructured":"Zhang X, Coker OO, Chu ES, Fu K, Lau HCH, Wang YX et al (2021) Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites. Gut 70. https:\/\/doi.org\/10.1136\/gutjnl-2019-319664","DOI":"10.1136\/gutjnl-2019-319664"},{"key":"12759_CR86","doi-asserted-by":"publisher","unstructured":"Marengo A, Rosso C, Bugianesi E (2016) Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis. Annu Rev Med 67. https:\/\/doi.org\/10.1146\/annurev-med-090514-013832","DOI":"10.1146\/annurev-med-090514-013832"},{"key":"12759_CR87","doi-asserted-by":"publisher","unstructured":"Tsuchida T, Lee YA, Fujiwara N, Ybanez M, Allen B, Martins S et al (2018) A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. J Hepatol 69. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.011","DOI":"10.1016\/j.jhep.2018.03.011"},{"key":"12759_CR88","doi-asserted-by":"publisher","unstructured":"Asgharpour A, Cazanave SC, Pacana T, Seneshaw M, Vincent R, Banini BA et al (2016) A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer. J Hepatol 65. https:\/\/doi.org\/10.1016\/j.jhep.2016.05.005","DOI":"10.1016\/j.jhep.2016.05.005"},{"key":"12759_CR89","doi-asserted-by":"publisher","first-page":"7558","DOI":"10.3390\/ijms25147558","volume":"25","author":"V Tambay","year":"2024","unstructured":"Tambay V, Raymond V-A, Voisin L, Meloche S, Bilodeau M (2024) Reprogramming of Glutamine Amino Acid Transporters Expression and Prognostic Significance in Hepatocellular Carcinoma. Int J Mol Sci 25:7558","journal-title":"Int J Mol Sci"},{"key":"12759_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2022.13538","volume":"24","author":"B Selenge","year":"2022","unstructured":"Selenge B, Yamada S, Morine Y, Ikemoto T, Saito Y, Takasu C et al (2022) Impact of L\u2013type amino acid transporter 3 on the prognosis of hepatocellular carcinoma. Oncol Lett 24:1\u20136","journal-title":"Oncol Lett"},{"key":"12759_CR91","doi-asserted-by":"publisher","first-page":"5584","DOI":"10.3390\/ijms25115584","volume":"25","author":"N Hu","year":"2024","unstructured":"Hu N, Li H, Tao C, Xiao T, Rong W (2024) The Role of Metabolic Reprogramming in the Tumor Immune Microenvironment: Mechanisms and Opportunities for Immunotherapy in Hepatocellular Carcinoma. Int J Mol Sci 25:5584","journal-title":"Int J Mol Sci"},{"key":"12759_CR92","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq7305","author":"G Cognet","year":"2024","unstructured":"Cognet G, Muir A (2024) Identifying metabolic limitations in the tumor microenvironment. Sci Adv. [cited 21 Feb 2025] https:\/\/doi.org\/10.1126\/sciadv.adq7305","journal-title":"Sci Adv"},{"key":"12759_CR93","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41417-024-00764-w","volume":"31","author":"F Safri","year":"2024","unstructured":"Safri F, Nguyen R, Zerehpooshnesfchi S, George J, Qiao L (2024) Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications. Cancer Gene Ther 31:1105\u20131112","journal-title":"Cancer Gene Ther"},{"key":"12759_CR94","doi-asserted-by":"publisher","unstructured":"Lu LC, Hsu CH, Hsu C, Cheng AL (2016) Tumor Heterogeneity in Hepatocellular Carcinoma: Facing the Challenges. Liver cancer 5. https:\/\/doi.org\/10.1159\/000367754","DOI":"10.1159\/000367754"},{"key":"12759_CR95","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2021.1976142","author":"H Wang","year":"2021","unstructured":"Wang H, Chen X, Calvisi DF (2021) Hepatocellular carcinoma (HCC): the most promising therapeutic targets in the preclinical arena based on tumor biology characteristics. Expert Opin Ther Targets. [cited 21 Feb 2025] https:\/\/doi.org\/10.1080\/14728222.2021.1976142","journal-title":"Expert Opin Ther Targets"},{"key":"12759_CR96","doi-asserted-by":"publisher","unstructured":"Marin S, Ramos AJ, Cano-Sancho G, Sanchis V (2013) Mycotoxins: occurrence, toxicology, and exposure assessment. Food Chem toxicology: Int J published Br Industrial Biol Res Association 60. https:\/\/doi.org\/10.1016\/j.fct.2013.07.047","DOI":"10.1016\/j.fct.2013.07.047"},{"key":"12759_CR97","doi-asserted-by":"publisher","unstructured":"Zhang J, Zhang W, Yang L, Zhao W, Liu Z, Wang E et al (2023) Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function. Phytomedicine: Int J phytotherapy phytopharmacology 109. https:\/\/doi.org\/10.1016\/j.phymed.2022.154589","DOI":"10.1016\/j.phymed.2022.154589"},{"key":"12759_CR98","doi-asserted-by":"publisher","DOI":"10.1177\/15330338241276889","author":"X-Y Zhang","year":"2024","unstructured":"Zhang X-Y, Luo M, Qin S, Fu W-G, Zhang M-Y, FXR (2024) MRP-1 and SLC7A5: New Targets for the Treatment of Hepatocellular Carcinoma. Technol Cancer Res Treat. [cited 21 Feb 2025] https:\/\/doi.org\/10.1177\/15330338241276889","journal-title":"Technol Cancer Res Treat"},{"key":"12759_CR99","doi-asserted-by":"publisher","first-page":"e248","DOI":"10.1002\/imt2.248","volume":"3","author":"Y Jin","year":"2024","unstructured":"Jin Y, Cai S, Zhou Y, Guo D, Zeng Y, Xu W et al (2024) Targeting SLC7A11\/xCT improves radiofrequency ablation efficacy of HCC by dendritic cells mediated anti-tumor immune response. iMeta 3:e248","journal-title":"iMeta"},{"key":"12759_CR100","doi-asserted-by":"publisher","unstructured":"De Lorenzo S, Tovoli F, Trevisani F (2022) Mechanisms of Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma. Cancers 14. https:\/\/doi.org\/10.3390\/cancers14194616","DOI":"10.3390\/cancers14194616"},{"key":"12759_CR101","doi-asserted-by":"publisher","unstructured":"Kopystecka A, Patryn R, Le\u015bniewska M, Budzy\u0144ska J, Kozio\u0142 I (2023) The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma-Literature Review. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms24119342","DOI":"10.3390\/ijms24119342"},{"key":"12759_CR102","doi-asserted-by":"publisher","unstructured":"Shi Z, Li Z, Jin B, Ye W, Wang L, Zhang S et al (2023) Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation. Clin translational Med 13. https:\/\/doi.org\/10.1002\/ctm2.1300","DOI":"10.1002\/ctm2.1300"},{"key":"12759_CR103","doi-asserted-by":"publisher","unstructured":"Herraez E, Lozano E, Macias RI, Vaquero J, Bujanda L, Banales JM et al (2013) Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib. Hepatology (Baltimore MD) 58. https:\/\/doi.org\/10.1002\/hep.26425","DOI":"10.1002\/hep.26425"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12759-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12759-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12759-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:08:32Z","timestamp":1789556912000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12759-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12759"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12759-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that no generative AI or AI-assisted tools were used for the preparation of this manuscript.","order":2,"name":"Ethics","label":"Generative AI or AI-assisted tools","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1582"}}